ArticleBMC sports science, medicine & rehabilitation2026
Pushing athletic performance boundaries with anodal transcranial direct current stimulation: an exploratory, pilot, randomized controlled study on strength and inflammation in elite weightlifters.
Article in BMC sports science, medicine & rehabilitation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTranscranial direct current stimulation (tDCS) has been proposed as a non-invasive neuromodulatory strategy to enhance motor performance and modulate inflammatory responses. However, its effects on strength capacity and physiological stress markers during complex resistance exercises in elite athletes remain underexplored.
methodsIn this exploratory, randomized, sham-controlled pilot study, ten elite male weightlifters (n = 10; active tDCS = 5, sham = 5) received either a single 20-min session of anodal tDCS (2 mA) over the motor cortex or sham stimulation immediately before performing high-load back squats (85% 1RM). Outcomes included repetition number, barbell kinematics, Borg Rating of Perceived Exertion (Borg-RPE), Visual Analogue Scale (VAS) measures, and metabolic and oxy-inflammatory biomarkers (blood glucose, lactate, antioxidant capacity; salivary ROS; urinary IL-6, 8-iso-PGF2α, 8-OH-dG, creatinine, and neopterin). Given the exploratory design and small sample size, intervention effects were analyzed using Mann-Whitney U tests. For outcomes assessed both before and after stimulation, between-group comparisons were performed on change scores (Δ = post - pre). In contrast, mechanical exercise-related variables, which were only collected after stimulation, were directly compared between the active and sham groups.
resultsAthletes receiving active tDCS performed a significantly higher number of back squat repetitions and exhibited shorter lift times compared with the sham group (p = 0.024 and p = 0.011, respectively). No significant between-group differences were observed in Borg-RPE, VAS-based subjective measures, or biochemical markers (all p > 0.05). No significant differences were found for the remaining mechanical parameters (all p > 0.05).
conclusionsA single session of anodal tDCS applied before high-load back squat exercise may be associated with improvements in repetition capacity and lifting efficiency in elite weightlifters. No significant effects were observed on perceived exertion, biomechanical stability measures, or metabolic, oxidative, inflammatory, and renal biomarkers. These preliminary findings suggest that tDCS may represent a promising neuromodulatory adjunct to strength training, warranting confirmation in larger and methodologically powered studies.
trial registrationNone (pilot study).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.